AEGIS CAPITAL CORP.
CRD #15007 SEC #801-71386 NEW YORK, NY 212-813-1010
SEC Registered Broker-Dealer Private Funds Disclosures
Total AUM
$1.4B
Discretionary
$631.9M
Employees
270
Clients
26
Accounts
2,760
| Fund Name | Type | GAV | Investors | Auditor |
|---|---|---|---|---|
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X | Private Equity Fund | $6.2M | 51 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X | Private Equity Fund | $6.2M | 51 | CITRIN COOPERMAN & COMPANY, LLP |
| AGRITECH QP PARTNERS LLC - SERIES HB-1 | Private Equity Fund | $5.7M | 294 | CITRIN COOPERMAN & COMPANY, LLP |
| AGRITECH QP PARTNERS LLC - SERIES HB-1 | Private Equity Fund | $5.7M | 294 | CITRIN COOPERMAN & COMPANY, LLP |
| AGRITECH QP PARTNERS LLC - SERIES HB-1 | Private Equity Fund | $5.7M | 294 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH I | Private Equity Fund | $5.6M | 51 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH I | Private Equity Fund | $5.6M | 51 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH I | Private Equity Fund | $5.6M | 51 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI | Private Equity Fund | $5.6M | 52 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI | Private Equity Fund | $5.6M | 52 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI | Private Equity Fund | $5.6M | 52 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI | Private Equity Fund | $5.5M | 98 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI | Private Equity Fund | $5.5M | 98 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI | Private Equity Fund | $5.5M | 98 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH IV | Private Equity Fund | $4.3M | 37 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH IV | Private Equity Fund | $4.3M | 37 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH IV | Private Equity Fund | $4.3M | 37 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA II | Private Equity Fund | $4.3M | 85 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA II | Private Equity Fund | $4.3M | 85 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA II | Private Equity Fund | $4.3M | 85 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VIII | Private Equity Fund | $4.2M | 47 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VIII | Private Equity Fund | $4.2M | 47 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VIII | Private Equity Fund | $4.2M | 47 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VIII | Private Equity Fund | $3.8M | 25 | CITRIN COOPERMAN & COMPANY, LLP |
| AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VIII | Private Equity Fund | $3.8M | 25 | CITRIN COOPERMAN & COMPANY, LLP |
TypePrivate Equity Fund
GAV$6.2M
Investors51
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$6.2M
Investors51
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.7M
Investors294
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.7M
Investors294
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.7M
Investors294
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.6M
Investors51
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.6M
Investors51
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.6M
Investors51
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.6M
Investors52
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.6M
Investors52
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.6M
Investors52
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.5M
Investors98
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.5M
Investors98
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$5.5M
Investors98
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.3M
Investors37
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.3M
Investors37
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.3M
Investors37
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.3M
Investors85
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.3M
Investors85
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.3M
Investors85
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.2M
Investors47
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.2M
Investors47
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$4.2M
Investors47
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$3.8M
Investors25
AuditorCITRIN COOPERMAN & COMPANY, LLP
TypePrivate Equity Fund
GAV$3.8M
Investors25
AuditorCITRIN COOPERMAN & COMPANY, LLP